Warner Bros. shares (WBD)

Key Updates

WBD shares declined 2.16% to $26.96 since the April 8 report, widening the merger arbitrage spread to 13.0% versus the $31.00 acquisition price. Today's shareholder meeting resulted in overwhelming approval of the Paramount Skydance merger, with shareholders voting in favor of the $110 billion transaction despite rejecting executive compensation packages including CEO David Zaslav's $550 million payout. The stock now trades 6.45% below its 2026 starting level, though it has gained 26.87% over the past six months as merger certainty increased.

Current Trend

WBD exhibits a negative YTD performance of -6.45%, underperforming the broader market despite the pending $31.00 per share acquisition. The stock trades at $26.96, maintaining a persistent 13.0% discount to the deal price, which reflects heightened regulatory uncertainty. Near-term resistance sits at the $27.55 level reached in early April, while the $31.00 acquisition price represents the ultimate upside target. The 26.87% six-month gain demonstrates the stock's rerating following the merger announcement, though recent weakness suggests growing market skepticism about deal completion within the Q3 2026 timeframe.

Investment Thesis

The investment case centers on merger arbitrage opportunity with a defined $31.00 per share exit price, representing 15.0% upside from current levels. The all-cash transaction eliminates equity market risk upon closing and provides downside protection through the $0.25 quarterly ticking fee if the deal extends beyond September 30, 2026. However, the thesis depends entirely on regulatory approval from the U.S. Department of Justice and European agencies, with legal experts indicating significant hurdles and potential blocking through litigation or legislation. The 13.0% spread compensates investors for regulatory risk and the 3-5 month wait until anticipated Q3 2026 closing.

Thesis Status

The investment thesis remains intact but faces elevated execution risk following today's shareholder approval. While the critical shareholder vote passed overwhelmingly, regulatory approval remains uncertain with potential lawsuits from state attorneys general expected. The widening arbitrage spread from 11.1% to 13.0% since early April signals declining market confidence in timely deal completion. The rejection of executive compensation packages, while not affecting the merger terms, highlights shareholder discontent and potential governance concerns. The thesis now carries higher binary risk, with regulatory clearance representing the primary catalyst for spread compression toward the $31.00 price.

Key Drivers

Regulatory approval timeline dominates near-term catalysts. The merger requires clearance from the U.S. Department of Justice and European regulatory agencies, with legal experts indicating significant regulatory hurdles. The companies target a July-September 2026 closing window, with shareholders entitled to a $0.25 per share quarterly ticking fee if the transaction does not close by September 30, 2026. The $110 billion transaction size will attract intense antitrust scrutiny given media industry consolidation concerns. Executive compensation controversy, particularly the rejected $550 million CEO payout, may create additional political pressure on regulators reviewing the deal.

Technical Analysis

WBD trades at $26.96, down 1.35% today and 2.16% since the April 8 report. The stock has established a trading range between $26.50-$27.55 over the past month, with the current price near the lower end of this consolidation pattern. The persistent 13.0% discount to the $31.00 deal price represents the widest spread since early April, indicating deteriorating deal completion confidence. Volume patterns around today's shareholder meeting will be critical to assess investor conviction. The six-month chart shows strong support at the $21-22 level from October 2025, representing the pre-merger announcement baseline. Any regulatory setback could trigger reversion toward these levels, while positive DOJ or European Commission signals would drive convergence toward $31.00.

Bull Case

• Shareholders voted overwhelmingly to approve the $110 billion merger with Paramount Skydance, eliminating a key approval hurdle and clearing the path for the $31.00 per share cash consideration, representing 15.0% upside from current levels.
• The merger has received unanimous approval from both companies' boards of directors, demonstrating strong management conviction in the strategic rationale and deal structure.
• Shareholders receive a $0.25 per share quarterly ticking fee if the transaction does not close by September 30, 2026, providing additional compensation for deal delays and reducing downside risk.
• The $31.00 per share price represents a 147% premium to the unaffected stock price of $12.54, demonstrating substantial value creation and making deal abandonment economically unattractive for the acquirer.
• The 26.87% six-month gain reflects strong momentum following merger announcement, with the stock establishing solid support above $26.50 and positioning for spread compression as the Q3 2026 closing timeline approaches.

Bear Case

• Legal experts have indicated the merger faces significant regulatory hurdles and could potentially be blocked or undone through litigation or legislation, creating substantial execution risk despite shareholder approval.
• The merger still requires approval from the U.S. Department of Justice and European regulatory agencies, with a potential lawsuit from state attorneys general expected, introducing multiple regulatory veto points that could derail the transaction.
• The 13.0% arbitrage spread has widened from 11.1% in early April, signaling declining market confidence in timely deal completion and increasing probability of regulatory delays or rejection.
• Shareholders rejected proposed executive compensation packages, including a $550 million payout to outgoing CEO David Zaslav, potentially creating political headwinds and negative optics that could influence regulatory review.
• The -6.45% YTD performance and recent -2.16% decline since the last report demonstrate continued selling pressure despite today's shareholder approval, suggesting institutional investors are reducing exposure due to regulatory uncertainty.